Reaction Details Report a problem with these data
Target
Histone H1.0
Ligand
BDBM50048803
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
15±0.0 nM
Citation
 Mates, S; Fienberg, A; Wennogle, L Methods and compositions for sleep disorders and other disorders US Patent  US8598119 Publication Date 12/3/2013 
Target
Name:
Histone H1.0
Synonyms:
H1-0 | H10_HUMAN | H1F0 | H1FV | Histone H1
Type:
Cell-surface receptors
Mol. Mass.:
20917.09
Organism:
Homo sapiens (Human)
Description:
P07305
Residue:
194
Sequence:
MTENSTSAPAAKPKRAKASKKSTDHPKYSDMIVAAIQAEKNRAGSSRQSIQKYIKSHYKVGENADSQIKLSIKRLVTTGVLKQTKGVGASGSFRLAKSDEPKKSVAFKKTKKEIKKVATPKKASKPKKAASKAPTKKPKATPVKKAKKKLAATPKKAKKPKTVKAKPVKASKPKKAKPVKPKAKSSAKRAGKKK
  
Inhibitor
Name:
BDBM50048803
Synonyms:
5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one | 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one | 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone) | 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one(Norastemizole) | CHEMBL708 | GEODON | ZIPRASIDONE | ZIPRASIDONE HYDROCHLORIDE
Type:
Small organic molecule
Emp. Form.:
C21H21ClN4OS
Mol. Mass.:
412.936
SMILES:
Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12
Structure:
Search PDB for entries with ligand similarity: